As first reported by Computer Weekly, Australian healthtech firm Medow Health AI has launched its real-time AI-powered medical scribe platform in Singapore, marking its first expansion into Southeast Asia. The platform, designed specifically for healthcare professionals, captures and structures clinical documentation during patient consultations — including notes, reports, and referrals — helping reduce time spent on administrative tasks and improving clinical accuracy. Already deployed in over 500 clinics across Australia, the solution has now been tailored for Singapore’s multilingual and digitally mature healthcare system.
Tailored for Singapore’s healthcare landscape
Medow’s system stands apart from general-purpose AI tools by focusing exclusively on the medical domain. Its models are trained to understand the complex language of healthcare and are customized to various specialties, producing detailed, structured notes with minimal need for editing.
Source: medowhealth.ai.
In Singapore, where the medical system serves a culturally diverse patient base, the scribe supports transcription in Mandarin, Cantonese, Malay, and Bahasa Indonesia — with plans to expand to Tamil and Hindi. The tool is already gaining traction, with 25 clinics onboarding in just the first three months.
Privacy-first approach with local data hosting
Recognizing the critical role of trust and safety in healthcare, Medow has designed its platform with “privacy by design.” Patient data is stored locally on Microsoft Azure servers in Singapore, with full encryption and strict adherence to the Personal Data Protection Act (PDPA). Doctors retain full control of all data, which is never sold or used to train third-party AI models. Informed consent is integrated into the clinical workflow, reinforcing ethical use and regulatory compliance.
Supporting Singapore’s digital health ambitions
Medow’s launch aligns with Singapore’s broader push to digitize healthcare. Local initiatives like SingHealth’s Note Buddy, NUHS’s Endeavour AI, and TTSH’s fall detection system show the city-state’s growing commitment to AI-enabled care. With the government pledging S$200 million to support innovation in public healthcare, platforms like Medow are well-positioned to support a more efficient and sustainable medical system. The company is now seeking partnerships with hospitals, associations, and networks to scale its impact across Singapore.
Medow Health AI’s entry into Singapore signals a significant step toward modernizing clinical workflows through intelligent automation. By combining domain-specific accuracy, multilingual support, and privacy-centric design, the platform exemplifies how targeted AI solutions can alleviate burdens on healthcare providers while enhancing patient care, all in alignment with Singapore’s vision for a digitally empowered health ecosystem.
